Abstract
To characterize the physiology of circulating IgA immune complexes (IgA-IC), the dynamics of IgA-IC removal by the liver were examined. After intravenous injection, covalently cross-linked IgA antibodies to the dinitrophenyl determinant were rapidly removed from the circulation by the liver. Immunofluorescence microscopy and light and electron microscope autoradiography showed that the IgA-IC were associated with Kupffer cells. With increasing doses of injected IgA-IC the clearance velocity approached a maximum, thus prolonging the circulation of IgA-IC. All these observations indicated a receptor-mediated process. Saturating doses of various potential receptor-blocking agents, heat-aggregated mouse IgG, microaggregated human serum albumin, and purified dimeric IgA did not influence the clearance pattern and hepatic uptake of radiolabeled IgA-IC. Mouse livers were also perfused via the portal vein with 1 microgram of IgA-IC. In the presence or absence of serum proteins, 43% of the perfused IgA-IC were removed in a single passage. This liver uptake was not reduced with simultaneous perfusion of large doses of aggregated mouse IgG, aggregated human serum albumin, or purified free dimeric mouse IgA. In contrast, the liver uptake of radiolabeled IgA-IC was decreased by 88% with the addition of 1 mg unlabeled IgA-IC. These observations support the conclusion that removal of IgA-IC from circulation is mediated by a specific IgA receptor on Kupffer cells.
MeSH Terms
Animals
Antibody Specificity
Antigen-Antibody Complex/metabolism
Antigens, CD
Female
Humans
Immunoglobulin A/metabolism
Immunoglobulin G/physiology
Kinetics
Kupffer Cells/metabolism,ultrastructure
Liver/metabolism
Mice
Mice, Inbred C57BL
Perfusion
Receptors, Fc/physiology
Chemicals
Antigen-Antibody Complex
Antigens, CD
Fc(alpha) receptor
Immunoglobulin A
Immunoglobulin G
Receptors, Fc
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Rifai A
Mannik M
References (26)
26 references, click to expand
-
In vivo and in vitro binding of IgA to the plasma membrane of hepatocytes.
Scand J Immunol. 1978;8(6):543-9
PMID: 366735
-
Clearance kinetics and fate of mouse IgA immune complexes prepared with monomeric or dimeric IgA.
J Immunol. 1983 Apr;130(4):1826-32
PMID: 6833754
-
Secretory component as the receptor for polymeric IgA on rat hepatocytes.
J Exp Med. 1979 Dec 1;150(6):1577-81
PMID: 512591
-
Effect of circulating immune complexes on Fc and C3 receptors of Kupffer cells in vivo.
Lab Invest. 1981 May;44(5):442-8
PMID: 7230730
-
Endocytosis.
Annu Rev Biochem. 1977;46:669-722
PMID: 332066
-
Experimental model for IgA nephropathy.
Clin Immunol Immunopathol. 1981 Sep;20(3):419-26
PMID: 6176379
-
High specific activity iodination of gamma-globulin with iodine-131 monochloride.
Cancer Res. 1960 Nov;20:1495-1500
PMID: 13713200
-
Activation of the guinea pig alternative complement pathway by mouse IgA immune complexes.
J Exp Med. 1982 Jan 1;155(1):231-47
PMID: 7054357
-
IGA in human bile and liver.
J Immunol. 1981 Feb;126(2):587-95
PMID: 6778920
-
Structural Aspects and Heterogeneity of Immunoglobulin Fc Receptors.
Adv Immunol. 1981;31:247-70
PMID: 7032255
-
Secretory component-dependent hepatic transport of IgA antibody-antigen complexes.
J Immunol. 1981 Jul;127(1):316-9
PMID: 7240746
-
The specificity of uptake of model immune complexes and other protein aggregates by the murine reticuloendothelial system.
J Immunol. 1980 Sep;125(3):1060-5
PMID: 7410828
-
An abnormality of immune complex kinetics in murine lupus.
J Immunol. 1981 Feb;126(2):770-4
PMID: 6161189
-
Stable model immune complexes produced by bivalent affinity labeling haptens: in-vivo survival.
Mol Immunol. 1979 Sep;16(9):721-9
PMID: 530279
-
Biosynthesis of immunoglobulin A (IgA). Secretion and addition of carbohydrate to monomer and polymer forms of a mouse myeloma protein.
Biochem J. 1973 Nov;136(3):589-96
PMID: 4205351
-
Hepatobiliary transport of IgA immune complexes: molecular and cellular aspects.
J Immunol. 1982 May;128(5):2183-6
PMID: 7061858
-
The elimination of circulating complexes containing polymeric IgA by excretion in the bile.
Immunology. 1981 Jan;42(1):83-9
PMID: 7461726
-
Experimental IgA nephropathy.
J Exp Med. 1979 Nov 1;150(5):1161-73
PMID: 159331
-
Changes in size, subclass, and metabolic properties of serum immunoglobulin A in liver diseases and in other diseases with high serum immunoglobulin A.
J Clin Invest. 1983 Feb;71(2):358-67
PMID: 6401770
-
Evaluation of aggregated IgG in mice as an Fc receptor specific probe of the hepatic mononuclear phagocyte system.
Clin Exp Immunol. 1982 Jul;49(1):200-8
PMID: 7127898
-
Saturation of the reticuloendothelial system with soluble immune complexes.
J Immunol. 1974 May;112(5):1939-48
PMID: 4818464
-
Interaction of aggregated -globulin with B lymphocytes.
J Exp Med. 1972 Jul 1;136(1):191-6
PMID: 4113510
-
IgA interaction with the asialoglycoprotein receptor.
Proc Natl Acad Sci U S A. 1982 Oct;79(20):6229-31
PMID: 6292896
-
Mesangial IgA nephritis.
Springer Semin Immunopathol. 1982;5(3):321-32
PMID: 6223392
-
Studies of reticuloendothelial function in the mouse with model immune complexes. I. Serum clearance and tissue uptake in normal C3H mice.
J Immunol. 1979 Oct;123(4):1594-9
PMID: 479594
-
Hepatic receptor that specifically binds oligosaccharides containing fucosyl alpha1 leads to 3 N-acetylglucosamine linkages.
Proc Natl Acad Sci U S A. 1978 May;75(5):2215-9
PMID: 276862